Omar Ammash advises emerging companies and venture capital investors involved in technology and other growth industries.

Mr. Ammash advises clients on a full range of matters and transactions, including:

  • Public and private financing transactions
  • Mergers and acquisitions
  • Corporate governance matters
  • Early-stage formation and strategy
  • Day-to-day corporate advice
  • Pre-IPO matters

With a robust cross-border practice, Mr. Ammash regularly advises clients based in India, Europe, and East Asia. 

While attending law school, he was a member of the Corporate Lab, a transactional-focused clinic, working on cutting-edge projects with multinational companies. 

Representative transactions include:

  • DNS, Drive Capital, and GreatPoint Ventures in various growth financings for numerous of their portfolio companies
  • ActiveCampaign in its US$240 million Series C financing
  • GTCR in connection with its sale of Inteliquent to Sinch
  • Henkel in its acquisition of Momentive’s consumer sealants division
  • Homie Technology in its:
    • US$30 million convertible note financing
    • US$23 million Series B financing
    • US$10 million Series A financing
  • Oscar Health in its US$1.4 billion IPO
  • Rivian in its multiple preferred stock financings and general company side matters
  • Sea Capital in its US$725 million financing of Forte
  • Sleeper in its US$40 million Series C funding round
  • SoftBank in its investments in:
    • Forward Health’s US$225 million Series D financing
    • Sprout Therapy’s US$219 million Series B financing
    • M1 Finance’s US$150 million Series E financing 

Bar Qualification

  • Illinois


  • J.D., University of Chicago, 2017
  • BA in Political Science, University of Minnesota, 2013
    summa cum laude